Mantis Biotech's 'Digital Twins' Aim to Solve Medical Data Shortage
Mantis Biotech is creating synthetic datasets to build digital replicas of the human body, addressing the lack of available medical data for AI research and development.
Why it matters
Mantis Biotech's digital twins can help solve the critical shortage of medical data that hinders the development of transformative AI applications in healthcare.
Key Points
- 1Mantis Biotech develops 'digital twins' of humans using disparate data sources
- 2These synthetic datasets represent human anatomy, physiology, and behavior
- 3The goal is to provide more data for AI-powered medical research and applications
Details
Mantis Biotech is tackling the challenge of limited medical data availability by creating 'digital twins' of humans. The company takes diverse data sources, such as clinical records, imaging scans, and wearable device data, to construct detailed synthetic datasets that can be used to build digital replicas of the human body. These digital twins accurately model anatomy, physiology, and even behavioral patterns. The availability of these large-scale, high-quality datasets can enable more effective AI-powered medical research, drug discovery, and personalized healthcare applications. As real-world medical data is often scarce, fragmented, or restricted, Mantis' approach provides a scalable solution to train and validate AI models without the typical data constraints.
No comments yet
Be the first to comment